Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan P Tyrer

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Nature Genetics|March 29, 2013
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancerPaul D P Pharoah, Ya-Yu Tsai, Susan J Ramus, et al.
Plos One|June 20, 2015
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) RiskGanna Chornokur, Hui-Yi Lin, Jonathan P Tyrer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2017
Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk ScoresJulie Lecarpentier, Valentina Silvestri, Karoline B Kuchenbaecker, et al.
Nature Communications|March 29, 2013
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31Jennifer Permuth-Wey, Kate Lawrenson, Howard C Shen, et al.
NPJ Genomic Medicine|November 20, 2025
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancerDaniel R Barnes, Jonathan P Tyrer, Joe Dennis, et al.
Nature Genetics|April 25, 2017
Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer riskFelix R Day, Deborah J Thompson, Hannes Helgason, et al.
Nature Communications|May 15, 2021
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriersJuliette Coignard, Michael Lush, Jonathan Beesley, et al.
Nature Communications|February 18, 2021
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriersJuliette Coignard, Michael Lush, Jonathan Beesley, et al.
European Journal of Human Genetics : EJHG|January 14, 2022
Polygenic risk modeling for prediction of epithelial ovarian cancer riskEileen O Dareng, Jonathan P Tyrer, Daniel R Barnes, et al.
European Journal of Human Genetics : EJHG|March 22, 2022
Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer riskEileen O Dareng, Jonathan P Tyrer, Daniel R Barnes, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Nature Genetics|March 29, 2013
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancerPaul D P Pharoah, Ya-Yu Tsai, Susan J Ramus, et al.
Plos One|June 20, 2015
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) RiskGanna Chornokur, Hui-Yi Lin, Jonathan P Tyrer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2017
Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk ScoresJulie Lecarpentier, Valentina Silvestri, Karoline B Kuchenbaecker, et al.
Nature Communications|March 29, 2013
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31Jennifer Permuth-Wey, Kate Lawrenson, Howard C Shen, et al.
NPJ Genomic Medicine|November 20, 2025
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancerDaniel R Barnes, Jonathan P Tyrer, Joe Dennis, et al.
Nature Genetics|April 25, 2017
Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer riskFelix R Day, Deborah J Thompson, Hannes Helgason, et al.
Nature Communications|May 15, 2021
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriersJuliette Coignard, Michael Lush, Jonathan Beesley, et al.
Nature Communications|February 18, 2021
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriersJuliette Coignard, Michael Lush, Jonathan Beesley, et al.
European Journal of Human Genetics : EJHG|January 14, 2022
Polygenic risk modeling for prediction of epithelial ovarian cancer riskEileen O Dareng, Jonathan P Tyrer, Daniel R Barnes, et al.
European Journal of Human Genetics : EJHG|March 22, 2022
Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer riskEileen O Dareng, Jonathan P Tyrer, Daniel R Barnes, et al.
Pageof 9